Inactive Instrument
Guided Therapeutics Inc Stock OTC Bulletin Board
Stocks
US40171F1057
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
OTC Bulletin Board
|
||
| - USD | - |
|
| Market Cap | 24.13M 20.91M 19.74M 17.9M 33.59M 2.31B 33.83M 236M 90.82M 1.17B 90.65M 88.65M 3.73B | P/E 2024 |
-3x | P/E 2025 | -12.7x |
|---|---|---|---|---|---|
| Enterprise Value | 27.01M 23.4M 22.09M 20.04M 37.59M 2.59B 37.86M 264M 102M 1.31B 101M 99.21M 4.18B | EV / Sales 2024 |
1,649x | EV / Sales 2025 | 64.4x |
| Free-Float |
63.48% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Faupel
CEO | Chief Executive Officer | 70 | 2023-03-05 |
| Chief Tech/Sci/R&D Officer | 70 | 2010-12-01 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Faupel
BRD | Director/Board Member | 70 | 2016-11-30 |
John Imhoff
BRD | Director/Board Member | 76 | 2006-04-09 |
Michael James
CHM | Chairman | 67 | 2013-09-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.62% | -0.03% | +27.98% | +19.00% | 227B | ||
| +1.55% | -2.12% | +6.95% | -19.82% | 143B | ||
| +2.38% | +3.07% | -15.95% | +24.43% | 134B | ||
| +4.82% | -5.75% | -56.14% | -14.87% | 65.29B | ||
| +1.99% | +0.96% | -18.12% | -13.93% | 50.09B | ||
| +1.36% | -4.87% | +10.25% | +15.54% | 49.29B | ||
| -0.09% | -2.69% | +19.12% | +27.79% | 41.39B | ||
| +0.41% | +0.15% | +38.80% | +50.73% | 40.28B | ||
| +2.16% | -2.35% | -17.45% | +51.04% | 31.9B | ||
| Average | +1.44% | -1.73% | -0.51% | +15.54% | 86.84B | |
| Weighted average by Cap. | +1.45% | -0.91% | +3.76% | +11.08% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7K 6.07K 5.72K 5.19K 9.74K 671K 9.81K 68.36K 26.34K 340K 26.29K 25.71K 1.08M | 767K 665K 627K 569K 1.07M 73.51M 1.08M 7.49M 2.89M 37.29M 2.88M 2.82M 119M |
| Net income | -2.42M -2.09M -1.98M -1.79M -3.36M -232M -3.39M -23.6M -9.1M -118M -9.08M -8.88M -374M | -3.2M -2.77M -2.61M -2.37M -4.45M -306M -4.48M -31.21M -12.03M -155M -12M -11.74M -494M |
| Net Debt | 1.77M 1.53M 1.45M 1.31M 2.46M 170M 2.48M 17.3M 6.66M 86.11M 6.65M 6.51M 274M | 2.88M 2.49M 2.35M 2.13M 4M 276M 4.03M 28.09M 10.82M 140M 10.8M 10.56M 445M |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
















